glp-1 and dpp-4 inhibitors Dipeptidyl peptidase-4 inhibitor DPP-4 inhibitors, known as gliptins,
Description
Read on as we answer these questions and more
J Neurosurg Anesthesiol 36(4): 278282

Kodera, R

Hammoud, E
One number may cover the clinical visit and prescription support only

Similarly, the evaluation of gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which occur frequently with GLP-1RAs (42) and have a major influence on the adherence to such treatment over time, have often been assessed in clinical trials solely via participant self-report, which is known to be unrelaible (eg, symptoms may not be volunteered due to embarrassment or poor recall) (43, 44)